JKT · SRAJ.JK
PT Sejahteraraya Anugrahjaya Tbk
IDR 10,850-IDR 125 (-1.14%)
PT Sejahteraraya Anugrahjaya Tbk’s quoted price sits in the lower half of its reported 52-week range, 43.49% below the high.
Loading market information…
JKT · MDLA.JK · IDR
Stock price, dividends
Quote as of Oct 30, 2026, 09:11 AM UTC. Cached market data; not a live quote.
One-year closing-price history · IDR. Historical prices are not a forecast.
Medela Potentia Tbk.’s quoted price sits in the lower half of its reported 52-week range, 36.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Medela Potentia Tbk.’s forward annual dividend is IDR 13 per share, paid annual. The forward yield is 6.6% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE COMPANY BEHIND THE TICKER
PT Medela Potentia Tbk produces and distributes a wide range of pharmaceutical and healthcare products throughout Indonesia and Cambodia. Its offerings include medical devices, spanning from consumable supplies to specialized equipment for hospitals and laboratories. The company also operates the GoApotik.com digital platform, an online channel that makes its products available to retailers, direct consumers, and patients. Founded in 2011, the firm is headquartered in Jakarta Selatan, Indonesia.
Latest available per-share figures in IDR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
IDR 10,850-IDR 125 (-1.14%)
PT Sejahteraraya Anugrahjaya Tbk’s quoted price sits in the lower half of its reported 52-week range, 43.49% below the high.
IDR 730+IDR 15 (+2.1%)
PT Kalbe Farma Tbk.’s quoted price sits in the lower half of its reported 52-week range, 45.52% below the high.
IDR 2,370-IDR 50 (-2.07%)
PT Enseval Putera Megatrading Tbk.’s quoted price sits in the lower half of its reported 52-week range, 18.28% below the high.
IDR 185-IDR 5 (-2.63%)
PT Jayamas Medica Industri Tbk’s quoted price sits in the lower half of its reported 52-week range, 41.82% below the high.
IDR 1,150+IDR 65 (+5.99%)
PT Mark Dynamics Indonesia Tbk’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
IDR 338-IDR 20 (-5.59%)
PT Kimia Farma (Persero) Tbk’s quoted price sits in the lower half of its reported 52-week range, 56.94% below the high.
IDR 350-IDR 4 (-1.13%)
PT Itama Ranoraya Tbk’s quoted price sits in the lower half of its reported 52-week range, 43.09% below the high.
IDR 198IDR 0 (0.0%)
PT Millennium Pharmacon International Tbk’s quoted price sits in the upper half of its reported 52-week range, 13.16% below the high.
